Literature DB >> 3769713

T3/T4 ratio in cimetidine treatment.

S Itoh, M Nakajima, Y Yamaba, S Matsuo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3769713     DOI： 10.1007/bf01296535

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  6 in total

1.  [Cholestatic hepatosis under Cimetidine].

Authors:  H Züchner
Journal:  Dtsch Med Wochenschr       Date:  1977-12-02       Impact factor: 0.628

2.  Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis.

Authors:  S Nomura; C S Pittman; J B Chambers; M W Buck; T Shimizu
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

3.  Early changes in the levels of serum triiodothyronine (T3), thyroxine (T4), T3/T4 ratio and microsomal carboxylesterase activity in rats following treatment with CCL4.

Authors:  S Itoh; Y Yamaba; S Matsuo; T Oda; T Satoh
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1985-09

4.  Effect of cimetidine on delta-aminolevulinic acid synthase and microsomal heme oxygenase in rat liver.

Authors:  D L Marcus; J L Halbrecht; A L Bourque; G Lew; H Nadel; M L Freedman
Journal:  Biochem Pharmacol       Date:  1984-07-01       Impact factor: 5.858

5.  Bridging hepatic necrosis associated with cimetidine.

Authors:  L Ruiz Del Arbol; V Moreira; A Moreno; F Hernández Ranz; A Cano; A García Plaza
Journal:  Am J Gastroenterol       Date:  1980-09       Impact factor: 10.864

6.  Cimetidine-induced hepatitis. Electron microscopic observations and clinical pattern of liver injury.

Authors:  I Lorenzini; A M Jezequel; F Orlandi
Journal:  Dig Dis Sci       Date:  1981-03       Impact factor: 3.199
  6 in total
  2 in total

Review 1.  Dosage regimen of cimetidine reviewed. Possible drug accumulation after multiple oral doses.

Authors:  J Prandota; I J Smith; J T Wilson
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Triiodothyronine level and triiodothyronine/thyroxine ratio in HBeAg-positive chronic hepatitis patients treated with prednisolone withdrawal.

Authors:  S Itoh; S Matsuo; T Oda; K Marutani; K Sasaki
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.